Anika Therapeutics Inc.

NASDAQ:ANIK  
40.10
-0.96 (-2.34%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)562.04M
Current PEN/A
Forward PE 802
2yr Forward PE 80.2
See more stats
Estimates Current Quarter
Revenue$34.51 Million
Adjusted EPS-$0.11
See more estimates
10-Day MA$42.75
50-Day MA$42.63
200-Day MA$38.95
See more pivots

Anika Therapeutics Inc. Stock, NASDAQ:ANIK

32 Wiggins Avenue, Bedford, Massachusetts 01730
United States of America
Phone: +1.781.457.9000
Number of Employees: 277

Description

Anika Therapeutics, Inc. is an orthopedic and regenerative medicines company, which develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration, and wound healing. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company was founded in 1992 and is headquartered in Bedford, MA.